Insmed Incorporated
Stock Forecast, Prediction & Price Target
Insmed Incorporated Financial Estimates
Insmed Incorporated Revenue Estimates
Insmed Incorporated EBITDA Estimates
Insmed Incorporated Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $188.46M N/A | $245.35M 30.19% | $305.20M 24.39% | Avg: $516.93M Low: $460.50M High: $555.46M avg. 69.37% | Avg: $901.46M Low: $815.14M High: $990.73M avg. 74.38% | Avg: $1.49B Low: $1.35B High: $1.64B avg. 65.75% | Avg: $2.12B Low: $1.92B High: $2.33B avg. 42.42% |
Net Income
% change YoY
| $-434.65M N/A | $-481.53M -10.78% | $-749.56M -55.66% | Avg: $-672.68M Low: $-787.82M High: $-432.53M avg. 10.25% | Avg: $-410.94M Low: $-460.62M High: $-196.60M avg. 38.91% | Avg: $30.71M Low: $26.89M High: $34.67M avg. 107.47% | Avg: $380.57M Low: $333.19M High: $429.56M avg. 1138.85% |
EBITDA
% change YoY
| $-373.37M N/A | $-458.20M -22.72% | $-654.73M -42.89% | Avg: $-516.93M Low: $-555.46M High: $-460.50M avg. 21.04% | Avg: $-901.46M Low: $-990.73M High: $-815.14M avg. -74.38% | Avg: $-1.49B Low: $-1.64B High: $-1.35B avg. -65.75% | Avg: $-2.12B Low: $-2.33B High: $-1.92B avg. -42.42% |
EPS
% change YoY
| -$3.88 N/A | -$3.91 -0.77% | -$5.34 -36.57% | Avg: -$4.03 Low: -$5.61 High: -$3.08 avg. 24.47% | Avg: -$2.28 Low: -$3.28 High: -$1.4 avg. 43.40% | Avg: $0.22 Low: $0.19 High: $0.25 avg. 109.58% | Avg: $2.71 Low: $2.37 High: $3.06 avg. 1138.85% |
Operating Expenses
% change YoY
| $512.06M N/A | $668.35M 30.52% | $949.26M 42.02% | Avg: $644.94M Low: $574.53M High: $693.01M avg. -32.05% | Avg: $1.12B Low: $1.01B High: $1.23B avg. 74.38% | Avg: $1.86B Low: $1.68B High: $2.04B avg. 65.75% | Avg: $2.65B Low: $2.40B High: $2.91B avg. 42.42% |
FAQ
What is Insmed Incorporated stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 323.87% in 2025-2028.
We have gathered data from 12 analysts. Their low estimate is -787.82M, average is -672.68M and high is -432.53M.
What is Insmed Incorporated stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 62.98% in 2025-2028.
We have gathered data from 12 analysts. Their low revenue estimate is $460.50M, average is $516.93M and high is $555.46M.
What is Insmed Incorporated stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 329.08% in 2025-2028.
We have gathered data from 12 analysts. Their low earnings per share estimate is -$5.61, average is -$4.03 and high is $-3.08.
What is the best performing analyst?
In the last twelve months analysts have been covering Insmed Incorporated stock. The most successful analyst is Vamil Divan.